Mesoblast cell treatment shows promise in rheumatoid arthritis -study

Aug 8 (Reuters) - Mesoblast Ltd on Monday said its experimental stem-cell treatment led to significant improvements of symptoms and disease activity in patients whose rheumatoid arthritis had stopped being helped by widely used biotech medicines, according to data from a mid-stage trial.